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Summary 
When stimulated through their antigen receptor, without costimulation, T  cells enter a state of 
antigen-specific  unresponsiveness,  termed  anergy.  B7-mediated  costimulation,  signaling  via 
CD28, is sufficient to prevent the induction ofanergy. Here we show that ligation ofT cell re- 
ceptor (TCR) by alloantigen alone, which results  in anergy, activates tyrosine phosphorylation 
of TCR~ and its association with fyn. In contrast, TCR ligation in the presence of B7 costim- 
ulation,  which  results in productive immunity,  activates tyrosine phosphorylation of TCtL~ 
and CD3 chains, which associate  with activated lck and zeta-associated protein (ZAP) 70. Un- 
der these conditions, CD28 associates  with activated lck and TCP,~.  These data suggest that 
the induction ofanergy is an active signaling process characterized by the association of TCR.~ 
and fyn. In addition, CD28-mediated costimulation may prevent the induction of anergy by 
facilitating the effective association of TCR~ and CD3e with the critical protein tyrosine kinase 
lck, and the subsequent recruitment of ZAP-70. Strategies to inhibit or activate TCtL-associ- 
ate& specific protein tyrosine kinase-mediated pathways may provide a basis for drug develop- 
ment with potential applications in the fields of transplantation, autoimmunity, and tumor im- 
munity. 
T 
o induce a productive T  cell immune response, signal- 
ing through the TCR. complex must result in T  cell 
activation, cytokine secretion, and clonal expansion. These 
events are mediated by a complex biochemical cascade ini- 
tiated by phosphorylation of the TCR. complex subunits, 
activation of  protein tyrosine kinases (PTKs) 1, protein phos- 
phorylation, and increased intracellular Ca  2+ levels (1). Al- 
though it is not clear which PTKs are involved in the initial 
signaling, there is compelling evidence that the tyrosine ki- 
nases fyn, lck, and zeta-associated protein (ZAP) 70 are im- 
plicated in the early signaling events (2-9). High efficiency 
TCR  cross-linking by mAbs  or high  density antigen  can 
induce the above mentioned biochemical events and gen- 
erate a productive T  cell response in vitro. 
However, under physiologic conditions, suboptimal cross- 
linking of TCR by antigen alone is  frequently not  suffi- 
cient to induce a productive immune response, but instead 
leads to long-term, antigen-specific unresponsiveness, termed 
anergy (10).  Under these conditions, T  cells require a con- 
tact-dependent costimulatory signal provided by the APCs 
IAbbreviations used in  th•  paper: PTK, protein tyrosine kinase; ZAP-70, 
zeta-associated protein 70. 
(11-13).  Increasing  evidence demonstrates  that  one  such 
critical costimulatory signal is provided by members of the 
B7 family to their ligand,  CD28,  on the  T  cells  (14-17). 
B7-mediated costimulation is sufficient to prevent the in- 
duction ofanergy (18-20). In the absence of B7 costimula- 
tion, cytokines (20-22) can also prevent the induction of T 
cell anergy.  It appears  that  their role is  mediated via  the 
common y  chain of the IL-2, IL-4, IL-7, and IL-15 recep- 
tors (23). Although the functional role of B7 costimulation 
is well established, the proximal biochemical events associ- 
ated with the induction ofanergy and its prevention by B7 
costimulation are ill understood. 
We attempted to determine the biochemical events asso- 
ciated with the induction ofanergy by alloantigen and induc- 
tion of  productive immunity by alloantigen in the presence 
of B7-mediated costimulation. We examined activation of 
protein tyrosine phosphorylation, the phosphorylation sta- 
tus of the TCl< components, and the tyrosine kinase activ- 
ity associated with TCI<~, CD3e, and CD28. In the results 
to be reported below, we demonstrate that during the in- 
duction of anergy, although protein tyrosine phosphoryla- 
tion  is  activated,  CD3~  is  not  phosphorylated  whereas 
TCI<~ is only partially phosphorylated and associates  with 
fyn. In contrast, during the induction of productive immu- 
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phorylation of ~  and  hyperphosphorylation of ~  chains  of 
the  TCP,.,  both  of which  associate with lck and  ZAP-70. 
Moreover, simultaneous TCP. and CD28 ligation by anti- 
gen  and  B7,  respectively, results  in  association  of CD28 
with TCI<~ and lck. Under these conditions, lck appears to 
be  involved in  the  phosphorylation of TCP.{,  potentially 
providing the  critical tyrosine kinase activity necessary for 
T  cells to proceed to successful TCR  signaling. 
Materials and Methods 
Human  T  Cell Clones.  HLA-DR7  alloantigen-specific T  cell 
clones TC-1,  TC-2,  and  TC-3  (CD4 +,  CD8-,  CD28 +,  B7-) 
were generated as previously described (24).  T  cell clones were 
rested for 10-14 d in IL-2 without alloantigen restimulation and 
before use, cells were cultured overnight in media. LBL-DP,7 is 
an EBV-transformed lymphoblastoid B cell line homozygous for 
HLA-DP,7 and expresses  adhesion and costimulatory molecules 
including B7-1  (CD80), B7-2  (CD86),  LFA-1 (CD11a), LFA-3 
(CD58),  and intercellular adhesion molecule 1 (CD54).  All ex- 
periments described here were done with three clones. 
NIH 3T3  Transfected Cells.  Alloantigen and/or costimulatory 
molecules were presented by use of NIH 3T3 stable transfectants 
(t-) that were constructed as previously described (19, 25). Tram- 
fectants expressing similar levels of DR and/or BT- 1 or B7-2 were 
selected for use. 
Antibodies  and Fusion  Proteins.  The  rabbit antipeptide antise- 
rum (N-23), used to inmmnoprecipitate TCR.~ chain, was kindly 
provided by Dr.  E.  Reinherz  (Harvard Medical School); anti- 
human TCP,~ mAb (TIA-2) (26), used to detect nonphosphory- 
lated  TCP,{  by  immunoblot,  was  kindly provided by  Dr.  P. 
Anderson  (Dana-Farber  Cancer  Institute,  Harvard  Medical 
School); anti-human CD3~  mAb (OKT3)  that binds to  human 
Cl)3e subunit (27), was purchased from American Type Culture 
Collection  (P, ockville, MD);  anti-CD28  (9.3)  mAb was  kindly 
provided by  Dr.  C. June  (Naval  Research  Institute,  Bethesda, 
MD); antiphosphotyrosine mAb (4G10)  (Upstate Biotechnology, 
Inc., Lake Placid, NY) was used for immunoblotting at 1:2,000; 
anti-lck and anti-fyn antisera (Santa  Cruz Biotechnology, Santa 
Cruz, CA) were used for immunoprecipitations at 2 I*l/test and 
for  imnmnoblotting at  1:1,000.  CTLA4-Ig is  a  fusion  protein 
consisting of the  extracdlular domain  of CTLA4  fused  to  the 
CH2 and CH3 domains of human IgG, and is a potent inhibitor 
orB7-1- and B7-2-mediated costimulation. CTLA4-Ig was con- 
structed and used as previously described (19). 
Primary and Secondary Stimulation.  T  cell  clones  were  incu- 
bated in 24 well plates (Nunc, Roskilde, Demnark) in a primary 
culture  with  either  t-DtL7,  t-DR7/B7-1,  t-DR7/B7-2,  LBL- 
I)R7, or LBL-DR7+CTLA4-Ig. After 48 h of primary culture, 
T  cell clones were  separated from LBL-DR7  by  Ficoll density 
centrifugation and from transfectants by Percoll gradient centrifu- 
gation, and cultured in media without IL-2 for 24 h. Each popu- 
lation  was  subsequently  rechallenged with  LBL-DR7  at  a  1:l 
stilnulator/responder ratio. Before use, LBL-DR7  and transfec- 
tants were treated with mitomycin-C as previously described (23). 
Thymidine Incorporation.  During the last 16 h of a 72-h culture 
period, cells were incubated with  1 exCi (37 kBq) of [methyl-3H] 
thymidine (Du Pont, Boston, MA). Thymidine incorporation was 
assessed as previously described (23) and was used as an index of 
mitogenic activity. 
Tyrosine Phosphotylation and hnmunoprecipitations.  For  activation 
of tyrosine phosphorylation, transfected stimulators were treated 
with mitomycin-C and cultured overnight in 24-well plates. T 
cell clones were added to the adhered transfectants  at a ratio of l:1, 
precipitated by fast spin, and cultured at 37~  Kinetics experi- 
ments for various time intervals (30 s-30 rain) showed that acti- 
vation of tyrosine phosphorylation was  first  observed at  1 rain, 
peaked at  10 min,  and declined thereafter (unpublished results). 
Therefore, in all subsequent experiments, activation of protein ty- 
rosine phosphorylation in whole cell lysates was  examined at  10 
min of culture.  Stimulation was stopped with cold wash buffer 
containing  PBS,  5  mM  EDTA,  10  mM  NaF,  and  0.4  mM 
Na3VO  4.  Cells were transferred into Eppendorf tubes and lysed 
with lysis buffer containing  10  inM  Tris-HC1,  pH  7.6,  5  mM 
EDTA,  50  mM  NaC1,  30  mM  NaqP207,  50  mM  NaF,  1 mM 
Na3VO 4,  aprotinin  (5  Ixg/ml),  pepstatin  (1  Ixg/ml),  soybean 
trypsin inhibitor (2 Ixg/ml), 1 mM PMSF, 0.5% Brij 96, and 0.5% 
NP-40 (Signna Chemical Co., St. Louis, MO). Whole cell lysates 
(2 ￿  1if' T cell equivalents/lane) were analyzed on 12.5% gels by 
SDS-PAGE.  Immunoprecipitations (107 cell equivalents/condi- 
tion) were performed with anti-TCR~ (N-23)  antiserum (1  Ixl/ 
sample)  or anti-CD3e  mAb  (2  Ixg/sample); proteins were  ana- 
lyzed by  10%  SDS-PAGE; and imnmnoblotting, stripping, and 
reblotting of the immunoblot were done as previously described 
(23).  lmmunoblotting was performed with: antiphosphotyrosine 
mAb (1:2,000);  anti-TCR~ mAb (TIA-2, 1:2,000);  specific anti- 
sera for ZAP-70, lck, and fyn (1:2,000)  (Santa  Cruz Biotechnol- 
ogy),  followed by  horseradish  peroxidase  anti-mouse  IgG  (1: 
3,000)  for  anti-phosphowrosine  and  anti-TCP,~  inmmnoblots, 
horseradish  peroxidase-protein A  (1:5,000,  Amersham  Corp., 
Arlington Heights, IL) for lck and fyn, or by horseradish peroxi- 
dase  anti-rabbit IgG  (1:10,000,  Promega  Corp.,  Madison,  WI) 
for  ZAP-70  immunoblots,  lmmunodetection  was  subsequently 
performed by enhanced chemiluminescence (Amersham Corp.). 
For two-dimensional electrophoresis, after  stmmlation, samples 
were lysed in either digitonin (10 mM Tris-HC1, pH 7.6,  5 mM 
EDTA,  50  mM  NaC1,  30  mM  Na4P207,  50  mM  NaF,  l  mM 
Na3VO4, aprotinin [5 Ixg/ml], pepstatin [1 /xg/ml], soybean trypsin 
inhibitor [2 Ixg/ml] 1 mM PMSF, and 1% digitonin) or NP-40 ly- 
sis buffer (10  mM Tris-HC1,  pH  7.6,  5  mM  EDTA,  50  mM 
NaC1,  30 mM Na4P2Ov, 50 mM NaF, 1 mM Na3VO 4, awotinin 
[5 txg/ml], pepstatin [1  Ixg/ml], soybean trypsin inhibitor [2 Ixg/ 
ml]  l  mM  PMSF,  and  1%  NP-40),  inmmnoprecipitated with 
anti-Cl)3e  or  anti-~  antibodies,  and  subjected  to  two-dimen- 
sional  (nonreducing/reducing)  SDS-PAGE  as  described  (26). 
Proteins were transferred on nitrocellulose membranes and sub- 
jected to antiphosphotyrosine immunoblot. 
Cell Surface Radio lodination and lmmunoprecipitation.  Cells  were 
washed, resuspended in 200  pA cold PBS, and labeled with  12sI 
(1 mCi per sample) by the lactoperoxidase method (28). After wash- 
ing three times in PBS to remove free iodine, cells were solubi- 
lized in digitonin lysis buffer precleared overnight with protein 
A-Sepharose (50  pul/test; Pharmacia Biotech, Uppsala, Sweden), 
10%  (vol/vol), and rabbit anti-mouse lg.  Immunoprecipitations 
were carried out in 500  ~zl lysis buffer using anti-CD3 mAb and 
rabbit anti-mouse Ig (1  Ixg/mg) for 2 h  at 4~  inmmne  con> 
plexes were isolated on protein A-Sepharose (5(1 txl/test), and an- 
alyzed by two-dimensional SDS-PAGE. Gels were dried and ra- 
diolabeled proteins were examined by autoradiography. 
N  Vitw Kinase Reactions and Phosphoamino Acid Analysis.  For  in 
vitro kinase assays cells were stinmlated for 5 rain at 37~  and ly- 
sates  were  prepared as above.  Kinetics experiments tbr various 
time intervals (30 s-30 rain) in our system  showed that tyrosine 
kinase activation was first observed at 30 s, peaked at 5 rain. and 
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quent experiments, PTK activation was examined at 5 min of cul- 
ture.  Cells were cultured  as indicated, lysates were prepared,  im- 
munoprecipitations  (5  X  10{'/condition)  were  conducted  with 
anti-TCR~ antiserum,  anti-CD3e, or anti-CD28  (2 Ixg/sample) 
mAb, immune complexes were isolated on protein A-Sepharose 
(50  p,l/sample), and in vitro kinase reactions were performed as 
previously described (29). Briefly, samples were washed twice in 
lysis buffer  (10 mM Tris-HCl, pH 7.6,  5 mM EDTA,  50 mM 
NaC1, 30 mM Na4P207, 50 mM NaF, 1 mM Na3VO4, aprotinin 
[5 pog/ml], pepstatin  [1  Ixg/ml], soybean trypsin inhibitor [2 Ixg/ 
ml] 1 mM PMSF, 0.5% Brij 96, and 0.5% NP-40) and once in ki- 
nase buffer  (20 mM Hepes, pH 7.2,  5 mM MgC12, and 5 mM 
MnC12). The immunprecipitates  were then suspended  in  40  Ixl 
kinase buffer containing  10 IxCi of ",/-[32p]ATP and incubated  at 
room temperature for 15 min. Reactions were terminated  by the 
addition  of 10 mM Hepes,  10 mM EDTA, washed  twice with 
double distilled H20, analyzed by 12.5% SDS-PAGE,  and trans- 
ferred  to polyvinyl  difluoride  (PVDF) membranes.  When  indi- 
cated,  membranes were  incubated  with  1 M  KOH for  1 h  at 
50~  and  exposed  to x-ray films. For analysis of reprecipitated 
antigen,  the immune kinase reaction  mixture was supplemented 
with 1% SDS, boiled for 5 min and diluted to 0.1% SDS with ly- 
sis buffer as described  previously  (30). The denatured  immuno- 
precipitates were reprecipitated  with the indicated antibodies. 
Phosphoaminoacid  analysis was  performed as  previously  de- 
scribed  (31). Briefly, in vitro phosphorylated  proteins  identified 
by autoradiography  were excised from the PVDF membrane, iso- 
lated by acid hydrolysis, and analyzed by one-dimensional  TLC. 
The identity  of the  radioactive  species was determined by com- 
parison to the position  of phosphoaminoacid standards that were 
visualized by ninhydrin. 
Results 
Differential Patterns of Tyrosine Phosphorylation are Generated 
after Signals that Are Associated with the Induction of Productive 
Immunity or Anergy.  Alloantigen-specific T  cell clones were 
primarily cultured with either t-DR7, t-DR7/B7-1, t-DR7/ 
B7-2,  or  LBL-DR7  in  the  absence  or  the  presence  of 
CTLA4-Ig.  To  determine  whether  the  various  primary 
culture  conditions  induced  anergy  or  productive  immu- 
nity, T  cell clones were rechallenged with LBL-DR7 stim- 
ulators.  Primary  culture  in  the  presence  of B7-mediated 
costimulation  (t-DR7/B7-1,  t-DR7/B7-2,  or LBL-DR7) 
resulted in a significant secondary response on rechallenge 
with LBL-DR7. In contrast, presentation of alloantigen in 
the primary culture in the absence of B7-mediated costim- 
ulation  (t-DR7 or LBL-DR7+CTLA4-Ig) resulted in an- 
ergy (Fig.  1 A). 
Because activation of protein tyrosine phosphorylation is 
the earliest biochemical event occurring after T  cell stimu- 
lation  (32),  we  examined whether  protein  tyrosine  phos- 
phorylation was activated after immunogenic or anergizing 
stimulation by alloantigen. T  cell clones were cultured with 
the same stimulators and protein tyrosine phosphorylation 
was examined in whole cell lysates by antiphosphotyrosine 
immunoblot.  Activation  of protein  tyrosine  phosphoryla- 
tion was observed under all culture conditions, but distinct 
patterns of protein tyrosine phosphorylation were activated 
by  anergizing  or  immunogenic  stimulation  (Fig.  1  B). 
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These results demonstrated that both induction  of anergy 
and productive immunity are associated with activation of 
signaling events. 
Multiple  Chains of TCR Become Tyrosine Phosphorylated af- 
ter Stimulation  by Alloantigen  and B7  Costimulation,  Whereas 
only  TCR~ Chain Becomes Phosphorylated after Stimulation  by 
Alloantigen Alone.  After  T  cell  activation ~,  8,  {,  and 
chains  of the  TCR  become  phosphorylated  (33-37).  In 
light  of the  differential patterns  of protein  tyrosine phos- 
phorylation noted in Fig.  1 B and the potential that some 
of these  might  represent  components  of the  TCR  com- 
plex, we examined whether TCR components were tyro- 
sine phosphorylated after stimulation by HLA-DR7 alloan- 
tigen with or without B7 mediated costimulation. Fig.  1 C 
depicts the TCR  components of the TC-1  clone as deter- 
mined by surface 125I labeling, anti-CD3e immunoprecipi- 
tation,  and  two-dimensional  gel  electrophoresis,  under 
conditions that do not dissociate the TCR components. To 
determine which TCR components are tyrosine phosphor- 
ylated after stimulation by alloantigen with or without B7 
mediated costimulation,  T  cells  were cultured with either 
t-DR7,  t-DR7/B7-1,  or  t-DR7/B7-2;  lysates were  pre- 
pared  in  digitonin  lysis  buffer,  immunoprecipitated  with 
anti-CD3e mAb and analyzed by two-dimensional nonre- 
ducing/reducing  gel  electrophoresis  and  antiphosphoty- 
rosine immunoblot. In comparison with clones cultured in 
media (Fig.  1 D), t-DR7 resulted in significant phosphory- 
lation  of the  TCR~  chain  and the  generation  of a  major 
21-kD  and  a  barely  discernible  18-kD  phosphoprotein 
(Fig.  1 E).  In contrast,  simultaneous stimulation via TCR 
and B7  (t-DR7/B7-1,  Fig.  1 F  or t-DR7/B7-2,  data not 
shown) resulted in phosphorylation of not only TCR~ but 
also  of TCR  ~,  g,  and ~.  Moreover,  under  these  culture 
conditions,  the pattern of electrophoretic migration of the 
phosphorylated  TCR~  chain  was  distinct  from  that  in- 
duced by t-DR7 and resulted in the generation of multiple 
phosphoproteins  with  electrophoretic  migration  ranging 
between 16 and 22 kD (Fig.  1 F). Solubilization in NP-40 
lysis buffer that dissociated TCR~ from the CD3  compo- 
nents, followed by immunoprecipitations with anti-TCR~- 
or anti-CD3~-specific antibodies  (data not shown)  further 
confirmed  that  the  phosphoproteins  induced  by  t-DR7 
represented phosphorylated ~ and those induced by t-DR7/ 
B7-1 represented phosphorylated and hyperphosphorylated 
and phosphorylated CD3 complex. These results demon- 
strate that immunogenic stimulation can activate phospho- 
rylation of% g, e, and ~ chains of the TCR, whereas aner- 
gizing stimulation results only in partial phosphorylation of 
chain. 
deter Anergizing  Stimulation  with Alloantigen,  TCR~  Can 
Be an In  Vitro Substrate for Activated fyn,  Whereas in the Pres- 
ence orB7 Costimulation,  TCR~ Can Be an In  Vitro Substrate 
for activated lck and ZAP-70.  In fight of our data that TCR~ 
was differentially phosphorylated under conditions that re- 
sulted in anergy or immunity, we examined whether spe- 
cific  PTK  activity  was  also  differentially  associated  with 
phosphorylated  TCR~.  Alloreactive  T  cell  clones  were 
stimulated and anti-TCR~ immunoprecipitations were ex- Figure  1.  (A)  TCR  signaling 
in the absence of B7 family co- 
stimulation  results in alloantigen- 
specific  clonal anergy. TC-1 
clone  was  primarily cultured 
with either t-DR7, t-DP.7/B7-1, 
t-DR/B7-2, LBL-DIL7, or LBL- 
DR7+CTLA4-Ig.  TC-I  cells 
were isolated from the  primary 
culture, rechallenged with LBL- 
Dl<7, and thymidine incorpora- 
tion was measured for the last 16 
of a 72-h culture period. P.esults 
are representative of 10 experi- 
ments. (B)  Anergizing and im- 
munogenic stimulation activate 
distinct patterns of protein ty- 
rosine  phosphorylation.  TC-I 
cells were incubated with the in- 
dicated stimulators /'or 10  rain, 
and activation  of protein tyrosine 
phospborylation was  examined 
in whole cell lysates by antiphos- 
photyrosine  imnmnoblot.  P,e- 
sults are representative of 15 ex- 
periments. (C)  Structure of the 
TCR  complex of TC-I  cells. 
TC-I (2 X 10  7) cells were radio- 
iodinated and  solubilized with 
lysis buflbr containing 1% di~to- 
nin; TCP, chains  were innmmo- 
precipitated with anti-CD3e mAb 
and analyzed  on two-dimensional 
nonreducing (NR)/reducing (R) 
diagonal gel electrophoresis, l<e- 
sults are  representative of three 
experiments. (D--I  ~)  Anergizmg 
and immunogenic  allo-APCs ac- 
tivate differential tyrosine phos- 
phorylation  of  TCR  compo- 
nents. TC-I cells were cultured 
with (D) media, (E) t-l)R7 allo- 
APCs, or (/3 t-DR7/B7-1  allo- 
APCs for  If)  rain. Cell ]ysates 
were prepared with lysis buffer 
containing  1%  digitonin. The 
TCR complex was imnmnopre- 
cipitated with anti-Ci)3e  mAb, 
separated by two-dimensional  nonreducing (NR)/reducing (R) diagonal  gel electrophoresis; tyrosine-phosphorylated  proteins were detected by antipbos- 
photyrosine immunoblot. Results are representative  of five experiments. 
amined for associated kinase activity by in vitro kinase reac- 
tions.  Unstimulated alloreactive T  cell clones contained a 
kinase activity constitutively associated with TCR{ that re- 
sulted in low background levels of in vitro  TCK~ phos- 
phorylation detectable  only after prolonged exposure,  al- 
though  the  associated  kinase could not be  seen  (data  not 
shown). After an anergizing signal, a significant increase in 
kinase  activity associated  with  TCR.~  could  be  detected. 
TCR~ was a substrate for in vitro tyrosine phosphorylation 
that  resulted  in  the  generation  of  16-,  18-,  and  21-kD 
bands. A band with a higher molecular mass of ~59-60 kD 
was also phosphorylated (Fig. 2 A). After an immunogenic 
signal, E-associated kinase(s) induced a different pattern of 
TCR{  phosphorylation resulting in the  generation of an 
additional 22-kD phosphorylated band, and new substrates 
of N56-60 and 70 kD were also  observed (Fig. 2 A). The 
identity of the activated TCR-associated PTKs after anergiz- 
ing or immunogenic stimulation was next investigated by 
reprecipitation experiments,  fyn  but  not  lck  or  ZAP-70 
could be reprecipitated from E-immune complexes after aner- 
gizing stimulation (Fig. 2  B).  In contrast, lck and ZAP-70, 
but not fyn, were  detected  in X-immune complexes after 
immunogenic stimulation (Fig. 2 B). 
The  nature  of  the  additional  22-kD  phosphorylated 
product observed after immunogenic stimulation was next 
examined  by  phosphoaminoacid  analysis  and  by  two- 
dimensional gel electrophoresis. Phosphoaminoacid analysis 
showed that both the 21- and 22-kD bands were phosphor- 
ylated on tyrosine and not serine or threonine (Fig.  2  C), 
indicating that the associated kinase activity was specific for 
tyrosine residues. Two dimensional nonreducing/reducing 
gel  electrophoresis  demonstrated  that  the  22-kD  phos- 
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identity as that ofphospho-~ (Fig. 2 D). 
After Anergizing  Stimulation with Alloantigen,  There Is No 
Increase in CD3E-assodated Tyrosine Kinase Activity,  Whereas in 
the Presence of B7 Costimulation, CD3e Can Be an In Vitro Sub- 
strate  for Activated fyn,  lck, and ZAP- 70.  CD3e  becomes 
phosphorylated after T  cell activation (37, 38) and has been 
shown to associate with PTK activity (38, 39). Since CD3{ 
was phosphorylated under immunogenic (Fig. 1 F) but not 
under anergizing conditions (Fig. 1 E), we sought to deter- 
mine whether the lack of e phosphorylation observed un- 
der anergizing culture conditions was due to the lack of as- 
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Figure  2.  Kinase activity associated with TCR~  immunoprecipitates after aner- 
gizing and immunogenic  stimulation.  (A)  TCR~  was  immunoprecipitated  from 
cell lysates of TC-1  (5  ￿  106) stimulated for 5 min at 37~  with the indicated stim- 
ulators,  and associated kinase activity was examined.  Exposure  time was 30 rain. 
Results  are  representative of six experiments.  (/3) Immunoprecipitations from A 
were boiled in  1% SDS,  diluted  10-fold in lysis buffer,  and reprecipitations with 
anti-@n, -lck, and -ZAP-70 antiserum were performed. Results are representative 
of four experiments. (C) Phosphoaminoacid analysis of the in vitro phosphorylated 
21-kD  (sample  1)  and 22-kD  (sample  2)  products  from TCR~  immunoprecipi- 
tates. The phosphorylated 21- and 22-kD products were hydrolyzed and examined 
for phosphoaminoacid content.  (Dashed drcles) Position of the phosphoaminoacid 
standards.  Results  are  representative  of two  experiments.  (D)  Analysis of the  in 
vitro substrates of TCR~-associated kinase activity by two-dimensional nonreduc- 
ing (NR)/reducing (R) diagonal gel electrophoresis. After stimulation with t-DR7/ 
B7-1,  immunoprecipitations and in vitro immune complex kinase reactions were 
performed and examined by two-dimensional nonreducing (NR)/reducing (R) di- 
agonal gel electrophoresis and autoradiography.  Results are representative of three 
experiments. sociation with activated PTKs. Nondiscemible levels of in 
vitro tyrosine kinase activity were  observed in  anti-CD3e 
immunprecipitates prepared from clones cultured with me- 
dia alone (Fig. 3 A) or control transfectants (data not shown). 
Interestingly,  no  CD3e-associated  kinase  activity  above 
background  levels  was  observed  after anergizing  stimula- 
tion.  In  contrast,  immunogenic  stimulation  significantly 
enhanced  the  CD3~-associated  kinase  activity and  gener- 
ated phosphorylated products of 23-25 kD which, as previ- 
ously  shown  (38),  represent  the  phosphorylated  subunits 
(% 8, and e) of the CD3 complex, and additional new sub- 
strates  of,',o56-70  kD  (Fig.  3  A).  It has been  shown  that 
CD3e constitutively associates with fyn PTK in a murine T 
cell hybridoma  (40)  and  can be induced  to  associate with 
ZAP-70 after receptor stimulation (38).  In addition, lck ac- 
tivity was shown to associate with CD3~  in  a leukemic T 
cell line  (HPB-ALL)  (41),  Jurkat,  and  peripheral blood T 
cells  (42).  Therefore, reprecipitation  of the in vitro kinase 
reaction  products  was performed with  PTK-specific anti- 
sera, which showed that fyn, lck, and ZAP-70 kinase activ- 
ity were detectable in CD3e-immune complexes after im- 
nmnogenic stimulation (Fig.  2 D). 
In Intact Cells, TCR~ Is Differentially Phosphorylated under 
Anergizing and Immunogenic Stimulation,  VVhereas CD3e Is Ty- 
rosine  Phosphorylated  Only  under  Immunogenic  Stimulation. 
In  vivo  induced  tyrosine  phosphorylation  of TCRi~  and 
CD3e  and  their  associated  kinases  under  anergizing  and 
immunogenic conditions was examined by antiphosphoty- 
rosine  immunoblot,  and  results  parallel  to  those  obtained 
by in vitro kinase reactions were observed (Fig.  4).  Anti-{ 
Figure 3.  Kinase  activity  associated with Cl)3e immunoprecipitates  af- 
ter anergizing and immunogenic stimulation. (A) CD3e was immunopre- 
cipitated from lysates  of  TC-1 cells (5 X 10  ~,) stimulated  for 5 rain at 37~ 
with the indicated stimulators, and associated kinase activity was exam- 
ined. Exposure time was 30 rain. Results are representative  of  four exper- 
iments. (B) R.eprecipitation  was performed  as described in Fig. 2 B. 
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immunoprecipitations  from T  cell  clones  stimulated  with 
anergizing stimuli demonstrated that TCI<{ underwent ty- 
rosine phosphorylation resulting in a major phosphorylated 
band of 21 kD and a minor band of 18 kD, which as previ- 
ously described,  represent phosphorylated forms of TCR~ 
(35-37).  In contrast,  anti-~ immunoprecipitation after im- 
munogenic  stimuli  demonstrated  the  generation  of two 
major 21-  and  22-kD phosphoproteins  and several minor 
phosphoproteins ranging from 16 to 18 kD. CD3e became 
phosphorylated after immunogenic but not anergizing stinm- 
lation.  Immunoblotting with  a  mAb that  detects  only the 
nonphosphorylated  form  of  TCP,.{,  showed  that  the 
amount of nonphosphorylated TCII.~ was reduced follow- 
ing  immunogenic  stimulation  as  compared  to  anergizing 
stimulation and unstimulated cells.  However, no quantita- 
tive comparison of the amounts ofphosphorylated and non- 
phosphorylated TCR{ could be done because of the differ- 
ent  affinities  of the  anti-phosphotyrosine  and  anti-TCR{ 
mAbs. No TCR{ was detectable in the anti-CD3~ immu- 
noprecipitations. 
The identity of several TCR.~- and CD3~-associated phos- 
phoproteins  under  various  culture  conditions  was  exam- 
ined by imnmnoblotting with PTK-specific antisera (Fig. 4), 
and  results  parallel  to  those  obtained  by  reprecipitations 
from  in  vitro  kinase  reaction  products  were  observed. 
However, no fyn was detected associated with CD3~ under 
anergizing  or  immunogenic  stimulation.  The  observation 
that fyn can be detected  in  reprecipitation  experiments as 
an  e-associated  in  vitro  phosphorylated  product  from  in 
vitro kinase reaction after immunogenic stinmlation (Fig. 3 B) 
is probably due to the higher sensitivity of the assay. 
After  TCR  Ligation  by Alloantigen  and  CD28  by  B7-1  or 
B7-2,  CD28 Becomes Associated with Activated lck and  TCR~. 
Since  t-DR7/B7-1  or  t-DP.7/B7-2  induced  a  significant 
increase in  tyrosine phosphorylation and generated similar 
TCI<~- and CD3e-associated PTK activity, We examined 
whether CD28 might be involved in the activation of asso- 
ciated kinase(s). Although CD28 immunoprecipitations from 
unstimulated cells or those stimulated with anergizing stim- 
ulus  (t-DR7)  did not  demonstrate significant kinase activ- 
ity,  immunoprecipitations  after  stimulation  with  t-Dlq.7/ 
B7-1  or  t-DR7/B7-2  demonstrated  nmltiple  associated 
phosphoproteins  (Fig.  5  A).  Reprecipitation  from  these 
irnnmne  complex  kinase  samples  with  anti-fyn,  lck,  and 
ZAP-70  antisera  demonstrated  that  CD28  was  associated 
with lck after immunogenic stimulation.  In two of six ex- 
periments, small quantities of fyn could also be detected in 
the CD28-immune complexes (Fig.  5  B). The observation 
that  CD28  was  associated  with  a  TCR-associated  kinase 
under  imnmnogenic stimulation  raised  the  possibility that 
simultaneous cross-linking of TCR. and CD28 by their re- 
spective ligands, might result in the physical association of 
TClq.  and  CD28,  so  that  potentially  they  share  common 
PTKs. Therefore, the presence of TCP.{ was examined in 
immune  complex  kinase  reactions  performed  on  CD28 
immunoprecipitations  after t-DI~7/B7-1  or  t-DP.7/B7-2 
sfmulation. Anti-TCP.~ immunoprecipitations from CD28- 
immune  complexes  after  t-DR7/B7-1  or  t-DR7/B7-2 
TCP. Association with Protein Tyrosine Kinases in Anergy and Imnmnity Figure 4.  Association of tyrosine phosphoproteins 
with TCR{ and r  after anergizing and immunogenic 
stimulation. T cells were stimulated with the indicated 
stimulators, lysates were prepared and immunoprecipi- 
tated with anti-TCR{  (A) or anti-CD3e (B) antibod- 
ies. After SDS-PAGE, proteins were transferred to ni- 
trocellulose  membranes  and  immunoblotted with 
antiphosphotyrosine mAb, anti-TCR~  mAb, or spe- 
cific antiserum for ZAP-70, lck, and fyn, followed by 
horseradish peroxidase anti-mouse  IgG, horseradish 
peroxidasv~protein A, or horseradish peroxidase anti- 
rabbit-lgG, as described in Materials and Methods. The 
band  observed at  r  kD  represents the  Ig heavy 
chain. In the ZAP-70 immunoblot, the heavy chain is 
more prominent in Fig. 3 A than in B because anti- 
TCR~ is a rabbit antipeptide antiserum, whereas anti- 
CD3~ is a mouse mAb. Results are representative of 12 
experiments. 
stimulation showed that the highly phosphorylated form of 
TCR~ (21/22 kD) was detected  (Fig. 5 B). 
Discussion 
Ever-mounting  evidence  supports  the  notion  that  B7 
family-mediated  costimulation  is  critical  for the induction 
of a successful primary immune response.  TCR  ligation in 
absence of B7 costimulation results in the induction of an- 
ergy, whereas  TCR  ligation accompanied by B7-mediated 
costimulation is sufficient to prevent anergy (18-20, 22, 43, 
44). The biologic significance of  this pathway has been well 
established  in  murine  models,  clearly  demonstrating  the 
role of B7 in the generation of autoimmunity (45-47),  tu- 
mor immunity (48-51),  and allograft rejection  (52). More- 
over, blockade of the B7:CD28 costimulatory pathway has 
been shown to inhibit humoral immunity (53), graft rejec- 
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tion  (54,  55),  GVHD  (56),  and to ameliorate  autoimmune 
disease (57, 58). Therefore, this pathway provides great po- 
tential  for the induction  and prevention  of immunity in  a 
variety of clinical settings. 
Although it is unclear how TCR  ligation leads to initia- 
tion of tyrosine phosphorylation,  fyn and lck appear to be 
directly implicated in the phosphorylation  of the  tyrosines 
within  the  immune  receptor  tyrosine  activation  motifs 
(ITAMs)  of the  TCR{  and  CD3  chains  (6,  38,  59).  Our 
data show that after anergizing stimulation,  fyn is associated 
with and can induce in vitro phosphorylation of TCR~ but 
not CD3{. In contrast, after immunogenic stimulation, lck is 
associated  with  and  can  induce  phosphorylation  of TCR{ 
and  ~  chains,  resulting  in  recruitment  and  association  of 
ZAP-70.  Since fyn is constitutively associated with both 
and  CD3  chains but has higher affinity for {  (60),  our re- 
suits  suggest that an anergizing stimulus can trigger fyn acti- Figure 5.  Association  of  CD28 with lck and hyperphosphory- 
lated TCR~ after simultaneous ligation of TCR and CD28. 
(A)  TC-1  cells (5  X  106) were  cultured with  either media, 
t-DR7, t-DR7/B7-1, or t-DR7/B7-2, for 5 min and associ- 
ated kinase activity in CD28  immunoprecipitates was exam- 
ined. (/3) After stimulation with t-DR7/B7-1 or t-DR7/B7-2 
and  anti-CD28  immunoprecipitations,  reprecipitations with 
anti-fyn, -lck, -ZAP-70 or -TCR~ antiserum were performed 
as in Fig. 2 B. Results are representative of six experiments. 
vation sufficient to phosphorylate  ~ but not %  B, or ~.  Pre- 
liminary results from our laboratory show  that fyn binding 
to  the  partially  phosphorylated  TCR{  after  anergizing 
stimulation  is  mediated  via  its  SH2  domain.  This  finding 
suggests  that  fyn,  which  is  constitutively  associated  with 
TCR  via its  NH2-terminal  site,  may be  the  first kinase  to 
initiate TCR  phosphorylation.  After receptor phosphoryla- 
tion, reorientation  offyn occurs which now associates with 
the  receptor  via its  SH2  domain.  Similar  observations  re- 
garding  reorientation  of protein  kinases  on  receptor-bind- 
ing sites have been reported in different systems (61). 
Alloantigen binding under anergizing conditions  induces 
fyn activation, generation of partially phosphorylated TCR~ 
(18  and  21  kD)  and  downstream-associated  substrates. 
These  events  result  in  partial  but  not  complete  functional 
outcome  of the immune response,  characterized  by upreg- 
ulation of cytokine receptors and induction  of low levels of 
IL-2  mRNA  but  no  proliferation  or  cytokine  accumula- 
tion.  If B7  costimulation  is  available,  additional  activation 
events  are  induced  resulting  in further  phosphorylation  of 
the  TCR/CD3  complex.  Under  these  conditions,  lck also 
becomes  activated  and  associates  with  TCR{  and  ~.  Al- 
though  {  can serve as in  vitro substrate  and become phos- 
phorylated  by lck  (41),  Gauen  et al.  (60)  have shown  that 
lck cannot  associate with  nonphosphorylated  {.  Therefore, 
fyn may initiate  and  lck may optimize  phosphorylation  of 
the  receptor.  Fully  phosphorylated  receptor  now  recruits 
ZAP-70 to bind via its dual SH2 domains. Partial phospho- 
rylation  of TCR{  after  an  anergizing  signal  can  generate 
phosphorylated  sites adequate  for fyn-SH2 binding but in- 
adequate  for ZAP-70  binding,  which,  because  of its struc- 
ture,  requires  binding  of both  its  SH2  domains  on  phos- 
phorylated  substrates,  indicating  that  ZAP-70  binds  only 
on doubly phosphorylated ITAMs (4, 62-65)  . 
Our data suggest that the induction  of anergy is an active 
signaling process characterized  by the association  of TCR{ 
and  fyn.  Whether  this  is  the  consequence  of specific  fyn- 
mediated events, or alternatively, the consequence  of inad- 
equate  activation  of lck and  ZAP-70  and  absence  of their 
associated biochemical events, remains to be determined.  It 
is  of note  that  in  two  distinct,  costimulation-independent 
systems in which anergy is induced  in vitro by altered pep- 
tide ligands  (66,  67)  or in vivo by superantigen  (68), partial 
TCR{  phosphorylation  and  absence  of ZAP-70  activation 
was reported,  underscoring the more general importance of 
this  observation  in  the  generation  of anergy.  Evidence  for 
the  association  of fyn with  the  state  of anergy  is less  well 
developed. However, Quill et al. (69) observed that anergic 
cells  expressed  higher  total  cellular  levels  of fyn  and  de- 
creased  levels  of lck  compared  with  unstimulated  or  pro- 
ductively stimulated  nmrine  T  cell clones.  In another  mu- 
rine  model,  increased  fyn  kinase  activity  was  detected  in 
anergized  cells  compared  with  productively  stimulated  or 
unstimulated  cells  (70).  In a human  system, the  association 
of fyn activation with  a  state of antigen-specific  unrespon- 
siveness  is supported  by a  recent  study  (71)  demonstrating 
that CD4 + T  cells from early HIV infection states are char- 
acterized  by  unresponsiveness  to  TCR-mediated  stimula- 
tion and exhibit high levels of fyn and low levels of lck ac- 
tivity.  Taken  together  with  the  above  results,  our  data 
suggest that fyn and lck do not have redundant  functions in 
early  T  cell  activation.  Consistent  with  this  hypothesis  is 
the observation that lck mutants,  which  demonstrate  levels 
offyn kinase comparable with their wild-type counterparts, 
fail to  activate tyrosine phosphorylation  or to express acti- 
vation  antigens  after  TCR  stimulation  (9).  Genetic  evi- 
dence derived from fyn- and lck-deficient mice also suggest 
that  the  in  vivo physiologic  roles  of these  tyrosine  kinases 
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highly significant defect in thymic maturation and the few 
remaining  mature  T  lymphocytes  are  hyporesponsive  to 
TCR-mediated signals  (7, 72). This profound defect argues 
that the alternative src kinase fyn cannot substitute for lck. 
In contrast,  fyn-deficient mice are relatively immunologi- 
cally intact and the only observed defect is the reduced ca- 
pacity of mature thymocytes to respond to TCR  stimula- 
tion  (2,  8).  Moreover,  functional  antigen-specific  clones 
have been  successfully generated from these  fyn-deficient 
mice (73). 
CD28 does not merely enhance the magnitude of TCR 
signal transduction but rather mediates activation of a dis- 
tinct signaling pathway. CD28-mediated signaling is resis- 
tant to cyclosporin A  (74),  generates novel lipids different 
from those generated by TCR cross-linking (75),  and acti- 
vates a specific DNA-binding complex that interacts with 
cytokine promoters (76,  77).  As shown here,  in the pres- 
ence of an anergizing stimulation, CD28 ligation results in 
productive functional outcome characterized by IL-2 accu- 
mulation,  proliferation,  activation  of a  distinct  pattern  of 
tyrosine  phosphorylation  of TCR  and  cytoplasmic  pro- 
teins,  and  association  of  TCR  with  lck  and  ZAP-70. 
Therefore,  although  the  downstream  pathways  of TCR 
and CD28 are distinct, CD28 cross-linking, independent of 
its  downstream  events,  modifies  the  initial  TCR  signal. 
Several groups have reported that CD28  cross-linking re- 
sults  in  a  low  but  consistent  lck  activation  (78-80).  Al- 
though  lck  activation  in  TCR-mediated  stimulation  is 
obligatory  (9),  its  significance  on  the  CD28  mediated 
downstream  events  is  still  unclear.  It has  been  suggested 
that PI-3 kinase binding to CD28,  as well as grb2/sos and 
ITK binding is dependent upon CD28 phosphorylation by 
src kinases, most notably lck (81).  However, stimulation of 
a lck-defective cell line with PMA and ionomycin in the 
presence  or  absence  of CD28  resulted  in  IL-2  secretion 
similar to  that  seen  in  the  wild  type,  suggesting  that  lck 
does not play an obligatory role in CD28 downstream sig- 
naling (82).  Therefore, CD28-mediated lck activation may 
not have a functional role on the CD28  downstream sig- 
naling, but rather, may be important for the initiation of a 
successful TCR signal. 
Although CD28 can associate with src family kinases af- 
ter cross-linking, CD28 does not have a constitutively asso- 
ciated  kinase  activity similar to  CD4  or CD8.  However, 
many recognition  events in the  immune system are initi- 
ated by aggregation of cell surface receptors that lack in- 
trinsic protein kinase activity. There is increasing evidence 
that src family kinases can associate with a number of cell 
surface molecules that are not members of the antigen re- 
ceptor  family,  including  CD2,  CD23,  CD36,  IL-2R[3 
chain,  and various phosphatidylinositol-anchored proteins, 
some of which also require simultaneous ligation of the an- 
tigen receptor to promote activation  (83-88).  A  potential 
explanation for this requirement is that the triggering motif 
on the antigen receptor acts as substrate for these src kinases 
allowing subsequent recruitment of ZAP kinase  (89).  Ag- 
gregation-induced  repartitioning  of enzyme and  substrate 
may be an important factor in redirecting an existing activ- 
ity towards the appropriate target. Indeed, our results show 
that after TCR  and CD28 ligation by antigen and B7  re- 
spectively, lck becomes associated not only with CD28 but 
also with TCR~. 
An intriguing explanation for the requirement of simul- 
taneous ligation of TCR  and  CD28  to induce  the  above 
discussed  biochemical  events  and  functional  outcome  is 
that  ligation  results in  redistribution  of the  surface  mole- 
cules in the T:APC contact patch so that TCR/CD3  and 
CD28 become components of a molecular complex. Un- 
der these circumstances, lck becomes activated and associ- 
ates with both CD28 and TCR, resulting in sufficient tyro- 
sine phosphorylation of the ITAMs and successful initiation 
of the  TCR-associated downstream signaling events.  The 
previous observation that both antigen and B7 have to be 
expressed on the same APC to induce an optimal response 
(20,  90) is consistent with this idea. The superior ability of 
ligand and costimulator coexpressed on the same APC  to 
activate T  cells  suggests  that  the  signals  delivered  by the 
TCR and the costimulatory molecule must be integrated at 
or near the T  cell surface membrane that is in contact with 
the APC (91). Whether additional molecules that may acti- 
vate associated lck are recruited to the complex remains to 
be determined. 
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